Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Eiamtrakarn, S; Itoh, Y; Kishimoto, J; Yoshikawa, Y; Shibata, N; Murakami, M; Takada, K
   Gastrointestinal mucoadhesive patch system (GI-MAPS) for oral administration of G-CSF, a model protein
   BIOMATERIALS
   
   S. Eiamtrakarn et al., "Gastrointestinal mucoadhesive patch system (GI-MAPS) for oral administration of G-CSF, a model protein", BIOMATERIAL, 23(1), 2002, pp. 145-152
2. Csar, XF; Wilson, NJ; Strike, P; Sparrow, L; McMahon, KA; Ward, AC; Hamilton, JA
   Copper/zinc superoxide dismutase is phosphorylated and modulated specifically by granulocyte-colony stimulating factor in myeloid cells
   PROTEOMICS
   
   X.F. Csar et al., "Copper/zinc superoxide dismutase is phosphorylated and modulated specifically by granulocyte-colony stimulating factor in myeloid cells", PROTEOMICS, 1(3), 2001, pp. 435-443
3. Wang, B; Ludden, TM; Cheung, EN; Schwab, GG; Roskos, LK
   Population pharmacokinetic-pharmacodynamic modeling of Filgrastim (r-metHuG-CSF) in healthy volunteers
   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
   
   B. Wang et al., "Population pharmacokinetic-pharmacodynamic modeling of Filgrastim (r-metHuG-CSF) in healthy volunteers", J PHARMA PH, 28(4), 2001, pp. 321-342
4. Morrison, VA; Picozzi, V; Scott, S; Pohlman, B; Dickman, E; Lee, M; Lawless, G; Kerr, R; Caggiano, V; Delgado, D; Fridman, M; Ford, J; Carter, WB
   The impact of age on delivered dose intensity and hospitalizations for febrile neutropenia in patients with intermediate-grade non-Hodgkin's lymphomareceiving initial CHOP chemotherapy: A risk factor analysis
   CLINICAL LYMPHOMA
   
   V.A. Morrison et al., "The impact of age on delivered dose intensity and hospitalizations for febrile neutropenia in patients with intermediate-grade non-Hodgkin's lymphomareceiving initial CHOP chemotherapy: A risk factor analysis", CLIN LYMPHO, 2(1), 2001, pp. 47-56
5. Hui, N; Le Marer, N
   alpha-2,6-sialylation regulation in CD34(+) progenitor cells in the human bone marrow and granulocyte colony-stimulating factor mobilization
   JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
   
   N. Hui e N. Le Marer, "alpha-2,6-sialylation regulation in CD34(+) progenitor cells in the human bone marrow and granulocyte colony-stimulating factor mobilization", J HEMATH ST, 10(5), 2001, pp. 661-668
6. Moog, R
   Adverse events in peripheral progenitor cell collection: A 7-year experience
   JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
   
   R. Moog, "Adverse events in peripheral progenitor cell collection: A 7-year experience", J HEMATH ST, 10(5), 2001, pp. 675-680
7. Gazitt, Y
   Recent developments in the regulation of peripheral blood stem cell mobilization and engraftment by cytokines, chemokines, and adhesion molecules
   JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
   
   Y. Gazitt, "Recent developments in the regulation of peripheral blood stem cell mobilization and engraftment by cytokines, chemokines, and adhesion molecules", J HEMATH ST, 10(2), 2001, pp. 229-236
8. Togel, F; Datta, C; Badbaran, A; Kroger, N; Renges, H; Gieseking, F; Janicke, F; Zander, AR; Kruger, W
   Urokinase-like plasminogen activator receptor expression on disseminated breast cancer cells
   JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
   
   F. Togel et al., "Urokinase-like plasminogen activator receptor expression on disseminated breast cancer cells", J HEMATH ST, 10(1), 2001, pp. 141-145
9. Gazitt, Y; Shaughnessy, P; Liu, Q
   Differential mobilization of CD34(+) cells and lymphoma cells in non-Hodgkin's lymphoma patients mobilized with different growth factors
   JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
   
   Y. Gazitt et al., "Differential mobilization of CD34(+) cells and lymphoma cells in non-Hodgkin's lymphoma patients mobilized with different growth factors", J HEMATH ST, 10(1), 2001, pp. 167-176
10. Gazitt, Y; Shaughnessy, P; Devore, P
    Mobilization of dendritic cells and NK cells in non-Hodgkin's lymphoma patients mobilized with different growth factors
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    
    Y. Gazitt et al., "Mobilization of dendritic cells and NK cells in non-Hodgkin's lymphoma patients mobilized with different growth factors", J HEMATH ST, 10(1), 2001, pp. 177-186
11. Estey, EH
    Growth factors in acute myeloid leukaemia
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    
    E.H. Estey, "Growth factors in acute myeloid leukaemia", BEST P R C, 14(1), 2001, pp. 175-187
12. Gurman, G; Dilek, I; Arslan, O; Arat, M; Beksac, M; Ilhan, O; Ozcan, M; Akan, H; Dalva, K; Konuk, N; Uysal, A; Koc, H
    The effect of G-CSF on lymphocyte subsets and CD34+cells in allogeneic stem cell transplantation
    TRANSFUSION AND APHERESIS SCIENCE
    
    G. Gurman et al., "The effect of G-CSF on lymphocyte subsets and CD34+cells in allogeneic stem cell transplantation", TRANSF AP S, 24(1), 2001, pp. 23-28
13. Bruserud, O; Foss, B; Petersen, H
    Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L)
    EUROPEAN CYTOKINE NETWORK
    
    O. Bruserud et al., "Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L)", EUR CYTOKIN, 12(2), 2001, pp. 231-238
14. Graf, L; Heimfeld, S; Torok-Storb, B
    Comparison of gene expression in CD34(+) cells from bone marrow and G-CSF-mobilized peripheral blood by high-density oligonucleotide array analysis
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    
    L. Graf et al., "Comparison of gene expression in CD34(+) cells from bone marrow and G-CSF-mobilized peripheral blood by high-density oligonucleotide array analysis", BIOL BLOOD, 7(9), 2001, pp. 486-494
15. Zaucha, JM; Zellmer, E; Georges, G; Little, MT; Storb, R; Storer, B; Torok-Storb, B
    G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    
    J.M. Zaucha et al., "G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required", BIOL BLOOD, 7(11), 2001, pp. 613-619
16. Bracho, F; Krailo, MD; Shen, V; Bergeron, S; Davenport, V; Liu-Mares, W; Blazar, BR; Panoskaltsis-Mortari, A; van de Ven, C; Secola, R; Ames, MM; Reid, JM; Reaman, GH; Cairo, MS
    A phase I clinical, pharmacological, and biological trial of interleukin 6plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: Enhanced hematological responses but a high incidence of grade III/IV constitutionaltoxicities
    CLINICAL CANCER RESEARCH
    
    F. Bracho et al., "A phase I clinical, pharmacological, and biological trial of interleukin 6plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: Enhanced hematological responses but a high incidence of grade III/IV constitutionaltoxicities", CLIN CANC R, 7(1), 2001, pp. 58-67
17. Banerjee, A; Shannon, KM
    Leukemic transformation in patients with severe congenital neutropenia
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    
    A. Banerjee e K.M. Shannon, "Leukemic transformation in patients with severe congenital neutropenia", J PED H ONC, 23(8), 2001, pp. 487-495
18. Ohls, RK; Bellis, YM; Dupree, JC; Sklar, LA
    Effects of granulocyte colony-stimulating factor on neutrophil adhesive molecules in neonates
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    
    R.K. Ohls et al., "Effects of granulocyte colony-stimulating factor on neutrophil adhesive molecules in neonates", J PED H ONC, 23(8), 2001, pp. 506-510
19. Goldman, SC; Bracho, F; Davenport, V; Slack, R; Areman, E; Shen, V; Lenarsky, C; Weinthal, J; Hughes, R; Cairo, MS
    Feasibility study of IL-11 and granulocyte colony-stimulating factor aftermyelosuppressive chemotherapy to mobilize peripheral blood stem cells fromheavily pretreated patients
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    
    S.C. Goldman et al., "Feasibility study of IL-11 and granulocyte colony-stimulating factor aftermyelosuppressive chemotherapy to mobilize peripheral blood stem cells fromheavily pretreated patients", J PED H ONC, 23(5), 2001, pp. 300-305
20. Cairo, MS
    Myelopoietic growth factors after stem cell transplantation: Does it pay
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    
    M.S. Cairo, "Myelopoietic growth factors after stem cell transplantation: Does it pay", J PED H ONC, 23(1), 2001, pp. 2-6
21. Cairo, MS; Shen, V; Krailo, MD; Bauer, M; Miser, JS; Sato, JK; Blatt, J; Blazar, BR; Frierdich, S; Liu-Mares, W; Reaman, GH
    Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children withrecurrent or refractory solid tumors: A Children's Cancer Group report
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    
    M.S. Cairo et al., "Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children withrecurrent or refractory solid tumors: A Children's Cancer Group report", J PED H ONC, 23(1), 2001, pp. 30-38
22. Davis, KA; Fabian, TC; Ragsdale, DN; Trenthem, LL; Croce, NA; Proctor, KG
    Combination therapy that targets secondary pulmonary changes after abdominal trauma
    SHOCK
    
    K.A. Davis et al., "Combination therapy that targets secondary pulmonary changes after abdominal trauma", SHOCK, 15(6), 2001, pp. 479-484
23. Gazitt, Y; Shaughnessy, P; Liu, Q
    Expression of adhesion molecules on CD34(+) cells in peripheral blood of non-Hodgkin's lymphoma patients mobilized with different growth factors
    STEM CELLS
    
    Y. Gazitt et al., "Expression of adhesion molecules on CD34(+) cells in peripheral blood of non-Hodgkin's lymphoma patients mobilized with different growth factors", STEM CELLS, 19(2), 2001, pp. 134-143
24. Gazitt, Y; Liu, Q
    Plasma levels of SDF-1 and expression of SDF-1 receptor on CD34(+) cells in mobilized peripheral blood of non-Hodgkin's lymphoma patients
    STEM CELLS
    
    Y. Gazitt e Q. Liu, "Plasma levels of SDF-1 and expression of SDF-1 receptor on CD34(+) cells in mobilized peripheral blood of non-Hodgkin's lymphoma patients", STEM CELLS, 19(1), 2001, pp. 37-45
25. Gutierrez-Delgado, F; Bensinger, W
    Safety of granulocyte colony-stimulating factor in normal donors
    CURRENT OPINION IN HEMATOLOGY
    
    F. Gutierrez-Delgado e W. Bensinger, "Safety of granulocyte colony-stimulating factor in normal donors", CURR OPIN H, 8(3), 2001, pp. 155-160
26. Hubel, K; Dale, DC; Liles, WC
    Granulocyte transfusion therapy: update on potential clinical applications
    CURRENT OPINION IN HEMATOLOGY
    
    K. Hubel et al., "Granulocyte transfusion therapy: update on potential clinical applications", CURR OPIN H, 8(3), 2001, pp. 161-164
27. Smith, MA; Smith, JG
    The use of granulocyte colony-stimulating factor for treatment of autoimmune neutropenia
    CURRENT OPINION IN HEMATOLOGY
    
    M.A. Smith e J.G. Smith, "The use of granulocyte colony-stimulating factor for treatment of autoimmune neutropenia", CURR OPIN H, 8(3), 2001, pp. 165-169
28. Santiago, E; Mora, L; Bautista, M; Montesinos, JJ; Martinez, I; Ramos, G; Zambrano, IR; Manrique, B; Weiss-Steider, B
    Granulocyte colony-stimulating factor induces neutrophils to secrete macrophage colony-stimulating factor
    CYTOKINE
    
    E. Santiago et al., "Granulocyte colony-stimulating factor induces neutrophils to secrete macrophage colony-stimulating factor", CYTOKINE, 15(6), 2001, pp. 299-304
29. Dunham, SP; Onions, DE
    Isolation, nucleotide sequence and expression of a cDNA encoding feline granulocyte colony-stimulating factor
    CYTOKINE
    
    S.P. Dunham e D.E. Onions, "Isolation, nucleotide sequence and expression of a cDNA encoding feline granulocyte colony-stimulating factor", CYTOKINE, 14(6), 2001, pp. 347-351
30. Vidarsson, B; Abonour, R; Williams, EC; Woodson, RD; Turman, NJ; Kim, K; Mosher, DF; Wiersma, SR; Longo, WL
    Fludarabine and cytarabine as a sequential infusion regimen for treatment of adults with recurrent, refractory or poor prognosis acute leukemia
    LEUKEMIA & LYMPHOMA
    
    B. Vidarsson et al., "Fludarabine and cytarabine as a sequential infusion regimen for treatment of adults with recurrent, refractory or poor prognosis acute leukemia", LEUK LYMPH, 41(3-4), 2001, pp. 321-331
31. Clavio, M; Gatto, S; Beltrami, G; Cerri, R; Carrara, P; Pierri, I; Canepa, L; Miglino, M; Balleari, E; Masoudi, B; Damasio, E; Ghio, R; Sessarego, M; Gobbi, M
    First line therapy with fludarabine combinations in 42 patients with either post myelodysplastic syndrome or therapy related acute myeloid leukaemia
    LEUKEMIA & LYMPHOMA
    
    M. Clavio et al., "First line therapy with fludarabine combinations in 42 patients with either post myelodysplastic syndrome or therapy related acute myeloid leukaemia", LEUK LYMPH, 40(3-4), 2001, pp. 305-313
32. Russo, D; Pricolo, G; Michieli, M; Michelutti, A; Raspadori, D; Bertone, A; Marin, L; Pierri, I; Bucalossi, A; Zuffa, E; De Vivo, A; Mazza, P; Gobbi, M; Lauria, F; Zaccaria, A; Baccarani, M
    Fludarabine, arabinosyl cytosine and idarubicin (FLAI) for remission induction in poor-risk acute myeloid leukemia
    LEUKEMIA & LYMPHOMA
    
    D. Russo et al., "Fludarabine, arabinosyl cytosine and idarubicin (FLAI) for remission induction in poor-risk acute myeloid leukemia", LEUK LYMPH, 40(3-4), 2001, pp. 335-343
33. Carella, AM
    Mini-ice protocol is better than high-dose hydroxyurea to mobilize Ph-negative cells in earlier phases of chronic myelogenous leukemia
    LEUKEMIA & LYMPHOMA
    
    A.M. Carella, "Mini-ice protocol is better than high-dose hydroxyurea to mobilize Ph-negative cells in earlier phases of chronic myelogenous leukemia", LEUK LYMPH, 40(3-4), 2001, pp. 447-448
34. Lorenz, W; Stinner, B; Bauhofer, A; Rothmund, M; Celik, I; Fingerhut, A; Koller, M; Lorijn, RHW; Nystrom, PO; Sitter, H; Schein, M; Solomkin, JS; Troidl, H; Wyatt, J; Wittmann, DH
    Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patientswith colorectal cancer and increased preoperative risk (ASA 3 and 4) - Protocol of a controlled clinical trial developed by consensus of an international study group - Part one: rationale and hypothesis
    INFLAMMATION RESEARCH
    
    W. Lorenz et al., "Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patientswith colorectal cancer and increased preoperative risk (ASA 3 and 4) - Protocol of a controlled clinical trial developed by consensus of an international study group - Part one: rationale and hypothesis", INFLAMM RES, 50(3), 2001, pp. 115-122
35. Ogawa, Y; Kobayashi, T; Nishioka, A; Kariya, S; Del Saz, EG; Seguchi, H; Yoshida, S
    Sudden termination of G-CSF injection leads to apoptosis of a large proportion of increased granulocytes
    ONCOLOGY REPORTS
    
    Y. Ogawa et al., "Sudden termination of G-CSF injection leads to apoptosis of a large proportion of increased granulocytes", ONCOL REP, 8(5), 2001, pp. 1027-1029
36. Oshita, F; Yamada, K; Nomura, I; Tanaka, G; Ikehara, M; Noda, K
    Randomized study of dose or schedule modification of granulocyte colony-stimulating factor in platinum-based chemotherapy for elderly patients with lung cancer
    ONCOLOGY REPORTS
    
    F. Oshita et al., "Randomized study of dose or schedule modification of granulocyte colony-stimulating factor in platinum-based chemotherapy for elderly patients with lung cancer", ONCOL REP, 8(4), 2001, pp. 861-866
37. Adachi, S; Itani, Y; Ito, K; Noda, T; Shintani, M; Saito, K; Furukawa, N; Tomii, Y
    Prognostic results of cisplatin IP and carboplatin IV with G-CSF in patients with ovarian cancer
    ONCOLOGY REPORTS
    
    S. Adachi et al., "Prognostic results of cisplatin IP and carboplatin IV with G-CSF in patients with ovarian cancer", ONCOL REP, 8(1), 2001, pp. 27-31
38. Peck, KR; Son, DW; Song, JH; Kim, S; Oh, MD; Choe, KW
    Enhanced neutrophil functions by recombinant human granulocyte colony-stimulating factor in diabetic patients with foot infections in vitro
    JOURNAL OF KOREAN MEDICAL SCIENCE
    
    K.R. Peck et al., "Enhanced neutrophil functions by recombinant human granulocyte colony-stimulating factor in diabetic patients with foot infections in vitro", J KOR MED S, 16(1), 2001, pp. 39-44
39. Palmblad, J; Papadaki, HA; Eliopoulos, G
    Acute and chronic neutropenias. What is new?
    JOURNAL OF INTERNAL MEDICINE
    
    J. Palmblad et al., "Acute and chronic neutropenias. What is new?", J INTERN M, 250(6), 2001, pp. 476-491
40. Lehmbecher, T
    Hematopoietic growth factors in prophylaxis and treatment of infectious complications in neonates
    ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE
    
    T. Lehmbecher, "Hematopoietic growth factors in prophylaxis and treatment of infectious complications in neonates", Z GEBU NEON, 205(5), 2001, pp. 167-173
41. Kern, W; Schleyer, E; Braess, J; Wittmer, E; Ohnesorge, J; Unterhalt, M; Wormann, B; Buchner, T; Hiddemann, W
    Efficacy of fludarabine, intermittent sequential high-dose cytosine arabinoside, and mitoxantrone [FIS-HAM] salvage therapy in highly resistant acuteleukemias
    ANNALS OF HEMATOLOGY
    
    W. Kern et al., "Efficacy of fludarabine, intermittent sequential high-dose cytosine arabinoside, and mitoxantrone [FIS-HAM] salvage therapy in highly resistant acuteleukemias", ANN HEMATOL, 80(6), 2001, pp. 334-339
42. Engelhardt, M; Bertz, H; Wasch, R; Finke, J
    Analysis of stem cell apheresis products using intermediate-dose filgrastim plus large volume apheresis for allogeneic transplantation
    ANNALS OF HEMATOLOGY
    
    M. Engelhardt et al., "Analysis of stem cell apheresis products using intermediate-dose filgrastim plus large volume apheresis for allogeneic transplantation", ANN HEMATOL, 80(4), 2001, pp. 201-208
43. Dreger, P; Schmitz, N
    Allogeneic transplantation of blood stem cells: Coming of age?
    ANNALS OF HEMATOLOGY
    
    P. Dreger e N. Schmitz, "Allogeneic transplantation of blood stem cells: Coming of age?", ANN HEMATOL, 80(3), 2001, pp. 127-136
44. Junghanss, C; Leithauser, M; Wilhelm, S; Kleine, HD; Knopp, A; Decker, S; Alscher, A; Casper, J; Kohne, CH; Freund, M
    High-dose etoposide phosphate and G-CSF mobilizes peripheral blood stem cells in patients that previously failed to mobilize
    ANNALS OF HEMATOLOGY
    
    C. Junghanss et al., "High-dose etoposide phosphate and G-CSF mobilizes peripheral blood stem cells in patients that previously failed to mobilize", ANN HEMATOL, 80(2), 2001, pp. 96-102
45. Eisenbeis, CF; Winn, D; Poelman, S; Polsky, CV; Rubenstein, JH; Olopade, OI
    A case of pulmonary toxicity associated with G-CSF and doxorubicin administration
    ANNALS OF HEMATOLOGY
    
    C.F. Eisenbeis et al., "A case of pulmonary toxicity associated with G-CSF and doxorubicin administration", ANN HEMATOL, 80(2), 2001, pp. 121-123
46. Dobo, I; Robillard, N; Pineau, D; Genevieve, F; Piard, N; Rapp, MJ; Boasson, M; Zandecki, M; Hermouet, S
    Use of pathology-specific peripheral blood CD34 thresholds to predict leukapheresis CD34 content with optimal accuracy: a bicentric analysis of 299 leukaphereses
    ANNALS OF HEMATOLOGY
    
    I. Dobo et al., "Use of pathology-specific peripheral blood CD34 thresholds to predict leukapheresis CD34 content with optimal accuracy: a bicentric analysis of 299 leukaphereses", ANN HEMATOL, 80(11), 2001, pp. 639-646
47. Voog, E; Le, QL; Philip, I; Benetaib, B; Michallet, M; Fiere, D; Thomas, X
    Autologous transplantation in acute myeloid leukemia: peripheral blood stem cell harvest after mobilization in steady state by granulocyte colony-stimulating factor alone
    ANNALS OF HEMATOLOGY
    
    E. Voog et al., "Autologous transplantation in acute myeloid leukemia: peripheral blood stem cell harvest after mobilization in steady state by granulocyte colony-stimulating factor alone", ANN HEMATOL, 80(10), 2001, pp. 584-591
48. Perea, G; Sureda, A; Martino, R; Altes, A; Martinez, C; Cabezudo, E; Amill, B; Martin-Henao, GA; Gonzalez, Y; Munoz, L; Peyret, M; Brunet, S; Sierra, J
    Predictive factors for a successful mobilization of peripheral blood CD34(+) cells in multiple myeloma
    ANNALS OF HEMATOLOGY
    
    G. Perea et al., "Predictive factors for a successful mobilization of peripheral blood CD34(+) cells in multiple myeloma", ANN HEMATOL, 80(10), 2001, pp. 592-597
49. Ohishi, K; Katayama, N; Mitani, H; Araki, H; Masuya, M; Suzuki, H; Hoshino, N; Miyashita, H; Nishii, K; Kageyama, S; Minami, N; Shiku, H
    Efficient ex vivo generation of human dendritic cells from mobilized CD34(+) peripheral blood progenitors
    INTERNATIONAL JOURNAL OF HEMATOLOGY
    
    K. Ohishi et al., "Efficient ex vivo generation of human dendritic cells from mobilized CD34(+) peripheral blood progenitors", INT J HEMAT, 74(3), 2001, pp. 287-296
50. Chuncharunee, S; Intragumtornchai, T; Chaimongkol, B; Prayoonwiwat, W; Leelasiri, A; Lekhakula, A; Chansung, K; Yoshida, Y
    Treatment of myelodysplastic syndrome with low-dose human granulocyte colony-stimulating factor: A multicenter study
    INTERNATIONAL JOURNAL OF HEMATOLOGY
    
    S. Chuncharunee et al., "Treatment of myelodysplastic syndrome with low-dose human granulocyte colony-stimulating factor: A multicenter study", INT J HEMAT, 74(2), 2001, pp. 144-146
51. Cha, KE; Yoon, SY; Lee, KN
    Effect of granulocyte colony-stimulating factor on chemotherapeutic activity of cytosine arabinoside in acute leukemic cell lines
    INTERNATIONAL JOURNAL OF HEMATOLOGY
    
    K.E. Cha et al., "Effect of granulocyte colony-stimulating factor on chemotherapeutic activity of cytosine arabinoside in acute leukemic cell lines", INT J HEMAT, 73(2), 2001, pp. 199-205
52. Tanaka, H; Imamura, N; Oguma, N; Shintani, T; Tanaka, K; Hyodo, H; Oda, K; Kimura, A
    Acute myelogenous leukemia with PIG-A gene mutation evolved from aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome
    INTERNATIONAL JOURNAL OF HEMATOLOGY
    
    H. Tanaka et al., "Acute myelogenous leukemia with PIG-A gene mutation evolved from aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome", INT J HEMAT, 73(2), 2001, pp. 206-212
53. Kohda, K; Sakamaki, S; Matsunaga, T; Kuga, T; Fujimi, A; Konuma, Y; Kusakabe, T; Kogawa, K; Akiyama, T; Koike, K; Hirayama, Y; Sasagawa, Y; Nojiri, S; Hirata, Y; Nishisato, T; Niitsu, Y
    Long-term survival and late-onset complications of cancer patients treatedwith high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation
    INTERNATIONAL JOURNAL OF HEMATOLOGY
    
    K. Kohda et al., "Long-term survival and late-onset complications of cancer patients treatedwith high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation", INT J HEMAT, 73(2), 2001, pp. 251-257
54. Younes, A; Preti, HA; Hagemeister, FB; McLaughlin, P; Romaguera, JE; Rodriguez, MA; Samuels, BI; Palmer, JL; Cabanillas, F
    Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma
    ANNALS OF ONCOLOGY
    
    A. Younes et al., "Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma", ANN ONCOL, 12(7), 2001, pp. 923-927
55. Mayumi, E; Okuno, T; Ogawa, T; Kurata, K; Ishioka, H; Hamamoto, H; Ishiki, K; Maga, T; Okamoto, T; Yoshida, T; Ogura, Y
    Malignant fibrous histiocytoma of soft tissue producing granulocyte colony-stimulating factor
    INTERNAL MEDICINE
    
    E. Mayumi et al., "Malignant fibrous histiocytoma of soft tissue producing granulocyte colony-stimulating factor", INTERN MED, 40(6), 2001, pp. 536-540
56. Arcasoy, MO; Maun, NA; Perez, L; Forget, BG; Berliner, N
    Erythropoietin mediates terminal granulocytic differentiation of committedmyeloid cells with ectopic erythropoietin receptor expression
    EUROPEAN JOURNAL OF HAEMATOLOGY
    
    M.O. Arcasoy et al., "Erythropoietin mediates terminal granulocytic differentiation of committedmyeloid cells with ectopic erythropoietin receptor expression", EUR J HAEMA, 67(2), 2001, pp. 77-87
57. Papadaki, HA; Palmblad, J; Eliopoulos, GD
    Non-immune chronic idiopathic neutropenia of adult: an overview
    EUROPEAN JOURNAL OF HAEMATOLOGY
    
    H.A. Papadaki et al., "Non-immune chronic idiopathic neutropenia of adult: an overview", EUR J HAEMA, 67(1), 2001, pp. 35-44
58. De Waele, M; Renmans, W; Vander Gucht, K; Jochmans, K; Schots, R; Otten, J; Trullemans, F; Lacor, P; Van Riet, I
    Growth factor receptor profile of CD34(+) cells in AML and B-lineage ALL and in their normal bone marrow counterparts
    EUROPEAN JOURNAL OF HAEMATOLOGY
    
    M. De Waele et al., "Growth factor receptor profile of CD34(+) cells in AML and B-lineage ALL and in their normal bone marrow counterparts", EUR J HAEMA, 66(3), 2001, pp. 178-187
59. Aurlien, E; Holte, H; Kvaloy, S; Jakobsen, E; Rusten, LS; Kvalheim, G
    Combination chemotherapy containing mitoguazone, ifosfamide, methotrexate,etoposide (MIME) and G-CSF efficiently mobilize peripheral blood progenitor cells in heavily pre-treated relapsed lymphoma patients
    EUROPEAN JOURNAL OF HAEMATOLOGY
    
    E. Aurlien et al., "Combination chemotherapy containing mitoguazone, ifosfamide, methotrexate,etoposide (MIME) and G-CSF efficiently mobilize peripheral blood progenitor cells in heavily pre-treated relapsed lymphoma patients", EUR J HAEMA, 66, 2001, pp. 14-20
60. Mayer, J; Vasova, I; Koristek, Z; Navratil, M; Klabusay, M; Doubek, M; Vorlicek, J; Cernilova, I; Vodvarka, P; Petrakova, K
    Ifosfamide- and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma
    EUROPEAN JOURNAL OF HAEMATOLOGY
    
    J. Mayer et al., "Ifosfamide- and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma", EUR J HAEMA, 66, 2001, pp. 21-27
61. O'Connell, N; Gardiner, N; Duggan, C; Enright, H; Kennedy, MJ; McCann, SR; Daly, PA; Browne, PV
    Effective progenitor cell mobilization in lymphoproliferative disorders using ifosfamide, epirubicin and etoposide (IEV)
    EUROPEAN JOURNAL OF HAEMATOLOGY
    
    N. O'Connell et al., "Effective progenitor cell mobilization in lymphoproliferative disorders using ifosfamide, epirubicin and etoposide (IEV)", EUR J HAEMA, 66, 2001, pp. 33-36
62. Ji, SQ; Chen, HR; Xun, CQ; Wang, HX; Pan, SP; Xiao, MH
    The effect of G-CSF-stimulated donor marrow on engraftment and incidence of graft-versus-host disease in allogeneic bone marrow transplantation
    CLINICAL TRANSPLANTATION
    
    S.Q. Ji et al., "The effect of G-CSF-stimulated donor marrow on engraftment and incidence of graft-versus-host disease in allogeneic bone marrow transplantation", CLIN TRANSP, 15(5), 2001, pp. 317-323
63. Lee, SC; Ibdah, R; Van Valkenburgh, C; Rowold, E; Abegg, A; Donnelly, A; Klover, J; Merlin, S; McKearn, JP
    Phage display mutagenesis of the chimeric dual cytokine receptor agonist myelopoietin
    LEUKEMIA
    
    S.C. Lee et al., "Phage display mutagenesis of the chimeric dual cytokine receptor agonist myelopoietin", LEUKEMIA, 15(8), 2001, pp. 1277-1285
64. Schmidt-Mende, J; Tehranchi, R; Forsblom, AM; Joseph, B; Christensson, B; Fadeel, B; Zhivotovsky, B; Hellstrom-Lindberg, E
    Granulocyte colony-stimulating factor inhibits Fas-triggered apoptosis in bone marrow cells isolated from patients with refractory anemia with ringedsideroblasts
    LEUKEMIA
    
    J. Schmidt-Mende et al., "Granulocyte colony-stimulating factor inhibits Fas-triggered apoptosis in bone marrow cells isolated from patients with refractory anemia with ringedsideroblasts", LEUKEMIA, 15(5), 2001, pp. 742-751
65. Wang, W; Wang, X; Ward, AC; Touw, IP; Friedman, AD
    C/EBP alpha and G-CSF receptor signals cooperate to induce the myeloperoxidase and neutrophil elastase genes
    LEUKEMIA
    
    W. Wang et al., "C/EBP alpha and G-CSF receptor signals cooperate to induce the myeloperoxidase and neutrophil elastase genes", LEUKEMIA, 15(5), 2001, pp. 779-786
66. Lee, JJ; Chung, IJ; Park, MR; Kook, H; Hwang, TJ; Ryang, DW; Kim, HJ
    Clinical related efficacy of granulocyte transfusion therapy in patients with neutropenia-infections
    LEUKEMIA
    
    J.J. Lee et al., "Clinical related efficacy of granulocyte transfusion therapy in patients with neutropenia-infections", LEUKEMIA, 15(2), 2001, pp. 203-207
67. Smeets, M; Raymakers, R; Muus, P; Vierwinden, G; Linssen, P; Masereeuw, R; de Witte, T
    Cyclosporin increases cellular idarubicin and idarubicinol concentrations in relapsed or refractory AML mainly due to reduced systemic clearance
    LEUKEMIA
    
    M. Smeets et al., "Cyclosporin increases cellular idarubicin and idarubicinol concentrations in relapsed or refractory AML mainly due to reduced systemic clearance", LEUKEMIA, 15(1), 2001, pp. 80-88
68. Carlsson, G; Fasth, A
    Infantile genetic agranulocytosis, morbus Kostmann: Presentation of six cases from the original "Kostmann family" and a review
    ACTA PAEDIATRICA
    
    G. Carlsson e A. Fasth, "Infantile genetic agranulocytosis, morbus Kostmann: Presentation of six cases from the original "Kostmann family" and a review", ACT PAEDIAT, 90(7), 2001, pp. 757-764
69. Lubitz, PA; Dower, N; Krol, AL
    Cyclic neutropenia: An unusual disorder of granulopoiesis effectively treated with recombinant granulocyte colony-stimulating factor
    PEDIATRIC DERMATOLOGY
    
    P.A. Lubitz et al., "Cyclic neutropenia: An unusual disorder of granulopoiesis effectively treated with recombinant granulocyte colony-stimulating factor", PEDIAT DERM, 18(5), 2001, pp. 426-432
70. Korbling, M; Giralt, S; Khouri, I; Mirza, N; Donato, M; Anderlini, P; Fischer, H; Andreeff, M; McMannis, J; Champlin, R
    Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresis
    JOURNAL OF CLINICAL APHERESIS
    
    M. Korbling et al., "Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresis", J CLIN APH, 16(2), 2001, pp. 82-87
71. Dempke, W; Schmoll, HJ
    Possible new indications for the treatment with erythropoietin
    MEDIZINISCHE KLINIK
    
    W. Dempke e H.J. Schmoll, "Possible new indications for the treatment with erythropoietin", MED KLIN, 96(8), 2001, pp. 467-474
72. Menendez, P; del Canizo, MC; Orfao, A
    Immunophenotypic characteristics of PB-mobilised CD34(+) hematopoietic progenitor cells
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
    
    P. Menendez et al., "Immunophenotypic characteristics of PB-mobilised CD34(+) hematopoietic progenitor cells", J BIOL REG, 15(1), 2001, pp. 53-61
73. Henon, P; Sovalat, H; Bourderont, D
    Importance of CD34(+) cell subsets in autologous PBSC transplantation: theMulhouse experience using CD34(+)CD38(-) cells as predictive tool for hematopoietic engraftment
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
    
    P. Henon et al., "Importance of CD34(+) cell subsets in autologous PBSC transplantation: theMulhouse experience using CD34(+)CD38(-) cells as predictive tool for hematopoietic engraftment", J BIOL REG, 15(1), 2001, pp. 62-67
74. Clavio, M; Quintino, S; Masoudi, B; Carrara, S; Cerri, R; Pierri, I; Canepa, L; Miglino, M; Muner, P; Damasio, E; Gobbi, M
    Cost of de novo acute myeloid leukemia induction therapy in adults: Analysis of EORTC-GIMEMA AML10 and FLANG regimens
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    
    M. Clavio et al., "Cost of de novo acute myeloid leukemia induction therapy in adults: Analysis of EORTC-GIMEMA AML10 and FLANG regimens", J EXP CL C, 20(2), 2001, pp. 165-173
75. Ferrara, F; Morabito, F; Latagliata, R; Martino, B; Annunziata, M; Oliva, E; Schiavone, EM; Pollio, F; Palmieri, S; Gianfaldoni, G; Leoni, F
    Aggressive salvage treatment is not appropriate for the majority of elderly patients with acute myeloid leukemia relapsing after first complete remission
    HAEMATOLOGICA
    
    F. Ferrara et al., "Aggressive salvage treatment is not appropriate for the majority of elderly patients with acute myeloid leukemia relapsing after first complete remission", HAEMATOLOG, 86(8), 2001, pp. 814-820
76. Canales, MA; Fernandez-Jimenez, MC; Martin, A; Arrieta, R; Caballero, MD; Diez, J; Quevedo, E; Garcia-Bustos, J; San Miguel, JF; Hernandez-Navarro, F
    Identification of factors associated with poor peripheral blood progenitorcell mobilization in Hodgkin's disease
    HAEMATOLOGICA
    
    M.A. Canales et al., "Identification of factors associated with poor peripheral blood progenitorcell mobilization in Hodgkin's disease", HAEMATOLOG, 86(5), 2001, pp. 494-498
77. Sautois, B; Baudoux, E; Salmon, JP; Michaux, S; Schaaf-Lafontaine, N; Pereira, M; Paulus, JM; Fillet, G; Beguin, Y
    Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation
    HAEMATOLOGICA
    
    B. Sautois et al., "Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation", HAEMATOLOG, 86(11), 2001, pp. 1209-1218
78. Vicent, MG; Madero, L; Chamorro, L; Madero, R; Diaz, MA
    Comparative cost analysis of autologous peripheral blood progenitor cell and bone marrow transplantation in pediatric patients with malignancies
    HAEMATOLOGICA
    
    M.G. Vicent et al., "Comparative cost analysis of autologous peripheral blood progenitor cell and bone marrow transplantation in pediatric patients with malignancies", HAEMATOLOG, 86(10), 2001, pp. 1087-1094
79. Musto, P; Sanpaolo, G; D'Arena, G; Scalzulli, PR; Matera, R; Falcone, A; Bodenizza, C; Perla, G; Carotenuto, M
    Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone
    HAEMATOLOGICA
    
    P. Musto et al., "Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone", HAEMATOLOG, 86(1), 2001, pp. 44-51
80. Hanel, M; Friedrichsen, K; Hanel, A; Herbst, R; Morgner, A; Neser, S; Nicklisch, M; Teich, M; Ehninger, G; Fiedler, F
    Mito-FLAG as salvage therapy for relapsed and refractory acute myeloid leukemia
    ONKOLOGIE
    
    M. Hanel et al., "Mito-FLAG as salvage therapy for relapsed and refractory acute myeloid leukemia", ONKOLOGIE, 24(4), 2001, pp. 356-360
81. Mineishi, S; Saito, T; Kanda, Y; Tanosaki, R; Tobinai, K; Takaue, Y
    Delayed recovery of neutrophil counts after peripheral stem cell transplantation which improved with administration of a minimal dose of G-CSF: A case report
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    
    S. Mineishi et al., "Delayed recovery of neutrophil counts after peripheral stem cell transplantation which improved with administration of a minimal dose of G-CSF: A case report", JPN J CLIN, 31(1), 2001, pp. 43-45
82. Ji, SQ; Chen, HR; Wang, HX; Ma, JC; Pan, SP; Xue, M; Zhu, L; Liu, J; Xiao, MH; Zhou, LL
    Low incidence of severe aGVHD and accelerating hemopoietic reconstitution in Allo-BMT using lenograstim stimulated BM cells
    CHINESE MEDICAL JOURNAL
    
    S.Q. Ji et al., "Low incidence of severe aGVHD and accelerating hemopoietic reconstitution in Allo-BMT using lenograstim stimulated BM cells", CHIN MED J, 114(2), 2001, pp. 191-195
83. Baumann, MA; Paul, CC; Lemley-Gillespie, S; Oyster, M; Gomez-Cambronero, J
    Modulation of MEK activity during G-CSF signaling alters proliferative versus differentiative balancing
    AMERICAN JOURNAL OF HEMATOLOGY
    
    M.A. Baumann et al., "Modulation of MEK activity during G-CSF signaling alters proliferative versus differentiative balancing", AM J HEMAT, 68(2), 2001, pp. 99-105
84. van der Auwera, P; Platzer, E; Xu, ZX; Schulz, R; Feugeas, O; Capdeville, R; Edwards, DJ
    Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: Comparison with single and multiple daily doses of Filgrastim
    AMERICAN JOURNAL OF HEMATOLOGY
    
    P. van der Auwera et al., "Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: Comparison with single and multiple daily doses of Filgrastim", AM J HEMAT, 66(4), 2001, pp. 245-251
85. Keung, YK; Pettenati, MJ; Cruz, JM; Powell, BL; Woodruff, RD; Buss, DH
    Bone marrow cytogenetic abnormalities of aplastic anemia
    AMERICAN JOURNAL OF HEMATOLOGY
    
    Y.K. Keung et al., "Bone marrow cytogenetic abnormalities of aplastic anemia", AM J HEMAT, 66(3), 2001, pp. 167-171
86. Staar, S; Rudat, V; Stuetzer, H; Dietz, A; Volling, P; Schroeder, M; Flentje, M; Eckel, HE; Mueller, RP
    Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy-results of a multicentric randomized German trial in advanced head-and-neck cancer
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    
    S. Staar et al., "Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy-results of a multicentric randomized German trial in advanced head-and-neck cancer", INT J RAD O, 50(5), 2001, pp. 1161-1171
87. Sunami, K; Teshima, T; Nawa, Y; Hiramatsu, Y; Maeda, Y; Takenaka, K; Shinagawa, K; Ishimaru, F; Ikeda, K; Niiya, K; Harada, M
    Administration of granulocyte colony-stimulating factor induces hyporesponsiveness to lipopolysaccharide and impairs antigen-presenting function of peripheral blood monocytes
    EXPERIMENTAL HEMATOLOGY
    
    K. Sunami et al., "Administration of granulocyte colony-stimulating factor induces hyporesponsiveness to lipopolysaccharide and impairs antigen-presenting function of peripheral blood monocytes", EXP HEMATOL, 29(9), 2001, pp. 1117-1124
88. Fleming, WH; Mulcahy, JM; McKearn, JP; Streeter, PR
    Progenipoietin-1: A multifunctional agonist of the granulocyte colony-stimulating factor receptor and fetal liver tyrosine kinase-3 is a potent mobilizer of hematopoietic stem cells
    EXPERIMENTAL HEMATOLOGY
    
    W.H. Fleming et al., "Progenipoietin-1: A multifunctional agonist of the granulocyte colony-stimulating factor receptor and fetal liver tyrosine kinase-3 is a potent mobilizer of hematopoietic stem cells", EXP HEMATOL, 29(8), 2001, pp. 943-951
89. Fujita, T; Yamada, T; Hashiguchi, A; Fukushima, S; Kondoh, K; Fujimoto, J; Hata, J
    Augmentation of megakaryocytopoiesis within the hematopoietic microenvironment of human granulocyte colony-stimulating factor transgenic mice
    EXPERIMENTAL HEMATOLOGY
    
    T. Fujita et al., "Augmentation of megakaryocytopoiesis within the hematopoietic microenvironment of human granulocyte colony-stimulating factor transgenic mice", EXP HEMATOL, 29(8), 2001, pp. 1010-1018
90. Monahan, JB; Hood, WF; Welply, JK; Shieh, JJJ; Polazzi, JO; Li, X
    Bivalent binding and signaling characteristics of Leridistim, a novel chimeric dual agonist of interleukin-3 and granulocyte colony-stimulating factor receptors
    EXPERIMENTAL HEMATOLOGY
    
    J.B. Monahan et al., "Bivalent binding and signaling characteristics of Leridistim, a novel chimeric dual agonist of interleukin-3 and granulocyte colony-stimulating factor receptors", EXP HEMATOL, 29(4), 2001, pp. 416-424
91. Tayebi, H; Kuttler, F; Saaa, P; Lienard, A; Petracca, B; Lapierre, V; Ferrand, C; Fest, T; Cahn, JY; Blaise, D; Kuentz, M; Herve, P; Tiberghien, P; Robinet, E
    Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells
    EXPERIMENTAL HEMATOLOGY
    
    H. Tayebi et al., "Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells", EXP HEMATOL, 29(4), 2001, pp. 458-470
92. Lefebvre, P; Lin, J; Linzer, DIH; Cohen, I
    Murine prolactin-like protein E synergizes with human thrombopoietin to stimulate expansion of human megakaryocytes and their precursors
    EXPERIMENTAL HEMATOLOGY
    
    P. Lefebvre et al., "Murine prolactin-like protein E synergizes with human thrombopoietin to stimulate expansion of human megakaryocytes and their precursors", EXP HEMATOL, 29(1), 2001, pp. 51-58
93. Hattori, Y; Kato, H; Nitta, M; Takamoto, S
    Decrease of L-selectin expression on human CD34(+) cells on freeze-thawingand rapid recovery with short-term incubation
    EXPERIMENTAL HEMATOLOGY
    
    Y. Hattori et al., "Decrease of L-selectin expression on human CD34(+) cells on freeze-thawingand rapid recovery with short-term incubation", EXP HEMATOL, 29(1), 2001, pp. 114-122
94. Fornasiero, A; Ghiotto, C; Daniele, O; Favaretto, AG; D'Amanzo, P; Ziade, A
    Neoadjuvant moderately high-dose chemotherapy with rh-G-CSF in locally advanced breast carcinoma
    TUMORI
    
    A. Fornasiero et al., "Neoadjuvant moderately high-dose chemotherapy with rh-G-CSF in locally advanced breast carcinoma", TUMORI, 87(4), 2001, pp. 223-228
95. Lehrnbecher, T
    Hematopoietic growth factors in prophylaxis and therapy of infections complications in children with neutropenia
    KLINISCHE PADIATRIE
    
    T. Lehrnbecher, "Hematopoietic growth factors in prophylaxis and therapy of infections complications in children with neutropenia", KLIN PADIAT, 213(4), 2001, pp. 212-238
96. Lehrnbecher, T
    Hematopoietic growth factors in the prevention of infections complicationsin children with hematologic-oncologic diseases.
    KLINISCHE PADIATRIE
    
    T. Lehrnbecher, "Hematopoietic growth factors in the prevention of infections complicationsin children with hematologic-oncologic diseases.", KLIN PADIAT, 213, 2001, pp. A88-A102
97. Ishigami, T; Yoshida, H; Yusa, H; Yanagawa, T
    Gingival cancer suspected of producing granulocyte colony-stimulating factor: Report of a case
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
    
    T. Ishigami et al., "Gingival cancer suspected of producing granulocyte colony-stimulating factor: Report of a case", J ORAL MAX, 59(7), 2001, pp. 804-808
98. Arland, M; Leuner, S; Lange, S; Bartsch, R; Kahl, C; Florschutz, A; Franke, A; Hoffkes, HG
    Ifosfamide, epirubicin and granulocyte colony-stimulating factor: A regimen for successful mobilization of peripheral blood progenitor cells in patients with multiple myeloma
    HEMATOLOGICAL ONCOLOGY
    
    M. Arland et al., "Ifosfamide, epirubicin and granulocyte colony-stimulating factor: A regimen for successful mobilization of peripheral blood progenitor cells in patients with multiple myeloma", HEMATOL ONC, 19(2), 2001, pp. 59-66
99. Ener, RA; Meglathery, SB; Cuhaci, B; Topolsky, D; Styler, MJ; Crilley, P; Brodsky, I; Kahn, SB; King, RS
    Use of granulocyte colony-stimulating factor after high-dose chemotherapy and autologous peripheral blood stem cell transplantation - What is the optimal timing?
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    
    R.A. Ener et al., "Use of granulocyte colony-stimulating factor after high-dose chemotherapy and autologous peripheral blood stem cell transplantation - What is the optimal timing?", AM J CL ONC, 24(1), 2001, pp. 19-25
100. Yokoi, H; Nakata, M; Sawai, K; Yoshida, T; Koshikawa, M; Joyama, S; Tanaka, A; Goto, M; Ueda, S; Senzaki, H; Sugawara, A; Kuwahara, T
     Intraglomerular metastasis from pancreatic cancer
     AMERICAN JOURNAL OF KIDNEY DISEASES
     
     H. Yokoi et al., "Intraglomerular metastasis from pancreatic cancer", AM J KIDNEY, 37(6), 2001, pp. 1299-1303